"........... now discussing commercialization not weather or not Monepantel may work, or whether it will have adverse side effects etc. .........."
Absolutely Peet. Mt must really reckon he is holding the winning lotto ticket with this one. How often in ones career can you walk into an opportunity with this realizable potential. Drug production already (pretty much) complete, very low bar regards improving market position, major industry (MND), support with a strong advisor group to assist plus a long line of treatment opportunities to trial identifying a multi billion market potential.... and thats to say nothing of the support of a bunch of oh so lovely rusted on shareholders.
FDA Application for Orphan Drug Designation , PAA, MPL, page-341
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |